Literature DB >> 18978208

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.

Tiemo Katzenberger1, Jörg Kalla, Ellen Leich, Heike Stöcklein, Elena Hartmann, Sandra Barnickel, Swen Wessendorf, M Michaela Ott, Hans Konrad Müller-Hermelink, Andreas Rosenwald, German Ott.   

Abstract

Follicular lymphoma (FL) is a morphologically and genetically well-characterized B-cell non-Hodgkin lymphoma that can show predominantly follicular, combined follicular and diffuse, or predominantly diffuse growth patterns. Although approximately 85% of FLs harbor the translocation t(14;18)(q32;q21) and consistently display a follicular growth pattern, predominantly diffuse FLs are less well characterized on the phenotypical, molecular, and clinical level. We studied 35 predominantly diffuse FL by immunohistochemistry, classical chromosome banding analysis, fluorescence in situ hybridization (FISH), and gene expression profiling. A total of 28 of 29 analyzable cases lacked t(14;18), and 27 of 29 cases revealed a unifying chromosomal aberration, a deletion in 1p36. Morphologically, 12 FLs were grade 1 and 23 were grade 2, and the immunophenotype with frequent expression of CD10, BCL6, and CD23 was in line with a germinal center B-cell phenotype. The gene expression profiles of 4 predominantly diffuse FLs fell into the spectrum of typical FL, with a unique enrichment of specific gene signatures. Remarkably, patients with diffuse FL frequently presented with low clinical stage and large but localized inguinal tumors. These results suggest that predominantly diffuse FL represent a distinct subtype of t(14;18)-negative nodal FL with a unifying genetic alteration (deletion of 1p36) and characteristic clinical features.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18978208     DOI: 10.1182/blood-2008-07-168682

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Follicular lymphomas: a tapestry of common and contrasting threads.

Authors:  Elaine S Jaffe
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

Review 2.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

3.  Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.

Authors:  Ambrus Gángó; Bence Bátai; Martin Varga; Dóra Kapczár; Gergő Papp; Márta Marschalkó; Enikő Kuroli; Tamás Schneider; Judit Csomor; András Matolcsy; Csaba Bödör; Ágota Szepesi
Journal:  Virchows Arch       Date:  2018-06-01       Impact factor: 4.064

Review 4.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

Review 5.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

6.  Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.

Authors:  Heike Horn; Christopher Schmelter; Ellen Leich; Itziar Salaverria; Tiemo Katzenberger; M Michaela Ott; Jörg Kalla; Monica Romero; Reiner Siebert; Andreas Rosenwald; German Ott
Journal:  Haematologica       Date:  2011-06-09       Impact factor: 9.941

Review 7.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

8.  Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.

Authors:  E Leich; E Hoster; M Wartenberg; M Unterhalt; R Siebert; K Koch; W Klapper; M Engelhard; B Puppe; H Horn; A M Staiger; C Stuhlmann-Laeisz; H W Bernd; A C Feller; M Hummel; D Lenze; H Stein; S Hartmann; M L Hansmann; P Möller; W Hiddemann; M Dreyling; G Ott; A Rosenwald
Journal:  Leukemia       Date:  2015-12-01       Impact factor: 11.528

9.  Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.

Authors:  Dominik Nann; Joan Enric Ramis-Zaldivar; Inga Müller; Blanca Gonzalez-Farre; Janine Schmidt; Caoimhe Egan; Julia Salmeron-Villalobos; Guillem Clot; Sven Mattern; Franziska Otto; Barbara Mankel; Dolors Colomer; Olga Balagué; Vanessa Szablewski; Carmen Lome-Maldonado; Lorenzo Leoncini; Stefan Dojcinov; Andreas Chott; Christiane Copie-Bergman; Irina Bonzheim; Falko Fend; Elaine S Jaffe; Elias Campo; Itziar Salaverria; Leticia Quintanilla-Martinez
Journal:  Blood Adv       Date:  2020-11-24

10.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-03       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.